• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UPLC-PDA 析因设计辅助法同时测定人血浆中奥司他韦、地塞米松和瑞德西韦。

UPLC-PDA factorial design assisted method for simultaneous determination of oseltamivir, dexamethasone, and remdesivir in human plasma.

机构信息

Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia, 41522, Egypt.

Pharmaceutical Chemistry Department, Egyptian Drug Authority (EDA), Cairo, Egypt.

出版信息

Sci Rep. 2024 Sep 18;14(1):21758. doi: 10.1038/s41598-024-71413-3.

DOI:10.1038/s41598-024-71413-3
PMID:39294224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11411088/
Abstract

A green and simple UPLC method was developed and optimized, adopting a factorial design for simultaneous determination of oseltamivir phosphate and remdesivir with dexamethasone as a co-administered drug in human plasma and using daclatasvir dihydrochloride as an internal standard within 5 min. The separation was established on UPLC column BEH C 1.7 μm (2.1 100.0 mm) connected to UPLC pre-column BEH 1.7 μm (2.1 5.0 mm) at 50 °C with an injection volume of 10 μL. The photodiode array detector (PDA) was set at three wavelengths of 220, 315, and 245 nm for oseltamivir phosphate, the internal standard, and both dexamethasone and remdesivir, respectively. The mobile phase consisted of methanol and ammonium acetate solution (40 mM) adjusted to pH 4 in a ratio of 61.5:38.5 (v/v) with a flow rate of 0.25 mL min. The calibration curves were linear over 500.0-5000.0 ng mL for oseltamivir phosphate, over 10.0-500.0 ng mL and 500.0-5000.0 ng mL for dexamethasone, and over 20.0-500 ng mL and 500.0-5000.0 ng mL for remdesivir. The Gibbs free energy and Van't Hoff plots were used to investigate the effect of column oven temperatures on retention times. Fluoride-EDTA anticoagulant showed inhibition activity on the esterase enzyme in plasma. The proposed method was validated according to the M10 ICH, FDA, and EMA's bioanalytical guidelines. According to Eco-score, GAPI, and AGREE criteria, the proposed method was considered acceptable green.

摘要

建立并优化了一个绿色、简单的 UPLC 方法,采用析因设计,同时测定人血浆中奥司他韦磷酸盐和瑞德西韦,并用盐酸达拉他韦作为内标,在 5 分钟内完成分析。分离在 UPLC 柱 BEH C1.7μm(2.1×100.0mm)上进行,与 UPLC 预柱 BEH1.7μm(2.1×5.0mm)相连,柱温为 50℃,进样量为 10μL。二极管阵列检测器(PDA)分别在 220nm、315nm 和 245nm 处设置三个检测波长,用于检测奥司他韦磷酸盐、内标和地塞米松及瑞德西韦。流动相由甲醇和 40mM 乙酸铵溶液(pH4)组成,体积比为 61.5:38.5(v/v),流速为 0.25mL/min。奥司他韦磷酸盐的校准曲线在 500.0-5000.0ng/mL 范围内呈线性,地塞米松在 10.0-500.0ng/mL 和 500.0-5000.0ng/mL 范围内呈线性,瑞德西韦在 20.0-500ng/mL 和 500.0-5000.0ng/mL 范围内呈线性。采用 Gibbs 自由能和 Van't Hoff 图谱研究柱温对保留时间的影响。氟化物-EDTA 抗凝剂对血浆中的酯酶有抑制作用。该方法按照 ICH、FDA 和 EMA 的生物分析指南进行验证。根据 Eco-score、GAPI 和 AGREE 标准,该方法被认为是可接受的绿色方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/a0544004aa29/41598_2024_71413_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/5afafff99897/41598_2024_71413_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/1ed65b629cef/41598_2024_71413_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/c58e9c5ca19a/41598_2024_71413_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/558cf16581b6/41598_2024_71413_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/a0544004aa29/41598_2024_71413_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/5afafff99897/41598_2024_71413_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/1ed65b629cef/41598_2024_71413_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/c58e9c5ca19a/41598_2024_71413_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/558cf16581b6/41598_2024_71413_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2816/11411088/a0544004aa29/41598_2024_71413_Fig5_HTML.jpg

相似文献

1
UPLC-PDA factorial design assisted method for simultaneous determination of oseltamivir, dexamethasone, and remdesivir in human plasma.UPLC-PDA 析因设计辅助法同时测定人血浆中奥司他韦、地塞米松和瑞德西韦。
Sci Rep. 2024 Sep 18;14(1):21758. doi: 10.1038/s41598-024-71413-3.
2
Development of UPLC method for simultaneous assay of some COVID-19 drugs utilizing novel instrumental standard addition and factorial design.利用新型仪器内标加样法和析因设计建立 UPLC 同时测定几种 COVID-19 药物的方法。
Sci Rep. 2023 Apr 4;13(1):5466. doi: 10.1038/s41598-023-32405-x.
3
Quantitative determination of oseltamivir and oseltamivir carboxylate in human fluoride EDTA plasma including the ex vivo stability using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.采用高效液相色谱-电喷雾串联质谱法测定人氟乙二胺 EDTA 血浆中的奥司他韦及其羧酸酯,包括体外稳定性。
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Apr 1;891-892:57-63. doi: 10.1016/j.jchromb.2012.02.026. Epub 2012 Feb 23.
4
Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies.LC-MS/MS 法测定酸性人血浆中瑞德西韦及其代谢物 GS-441524 和 GS-704277 的方法学验证及其在 COVID-19 相关临床研究中的应用。
Anal Biochem. 2021 Mar 15;617:114118. doi: 10.1016/j.ab.2021.114118. Epub 2021 Jan 26.
5
Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma.开发并验证了一种简单、选择性强、灵敏度高的液相色谱-串联质谱法,用于人血浆中瑞德西韦的定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 May 1;1171:122641. doi: 10.1016/j.jchromb.2021.122641. Epub 2021 Mar 10.
6
Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient.采用液相色谱-串联质谱法对血浆瑞德西韦及其代谢物 GS-441524 进行定量分析。在一名新冠肺炎治疗患者中的应用。
Clin Chem Lab Med. 2020 Jun 22;58(9):1461-1468. doi: 10.1515/cclm-2020-0612. Print 2020 Aug 27.
7
Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat.定量高效液相色谱-串联质谱法测定瑞德西韦的活性代谢产物 Nuc 在大鼠体内的药代动力学。
Anal Bioanal Chem. 2021 Sep;413(23):5811-5820. doi: 10.1007/s00216-021-03561-8. Epub 2021 Jul 24.
8
In vitro and in vivo stability of oseltamivir within a bioequivalence trial.生物等效性试验中奥司他韦的体外和体内稳定性
Anal Bioanal Chem. 2016 May;408(14):3891-7. doi: 10.1007/s00216-016-9483-2. Epub 2016 Mar 22.
9
Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.液相色谱-串联质谱法测定血浆、唾液和尿液中奥司他韦及其代谢产物奥司他韦羧酸盐的方法开发与验证
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 1;859(1):74-83. doi: 10.1016/j.jchromb.2007.09.018. Epub 2007 Sep 19.
10
Development and Validation of HPLC Fluorescence and UPLC/DAD Stability-Indicating Methods for Determination of Hepatitis C Antiviral Agent Daclatasvir.用于测定丙型肝炎抗病毒药物达卡他韦的高效液相色谱荧光法和超高效液相色谱/二极管阵列检测稳定性指示方法的开发与验证
J AOAC Int. 2019 Jul 1;102(4):1125-1131. doi: 10.5740/jaoacint.18-0344. Epub 2019 Apr 2.

本文引用的文献

1
Development of UPLC method for simultaneous assay of some COVID-19 drugs utilizing novel instrumental standard addition and factorial design.利用新型仪器内标加样法和析因设计建立 UPLC 同时测定几种 COVID-19 药物的方法。
Sci Rep. 2023 Apr 4;13(1):5466. doi: 10.1038/s41598-023-32405-x.
2
Rapid and ecofriendly UPLC quantification of Remdesivir, Favipiravir and Dexamethasone for accurate therapeutic drug monitoring in Covid-19 Patient's plasma.快速且环保的超高效液相色谱法对瑞德西韦、法匹拉韦和地塞米松进行定量分析,用于准确监测新冠肺炎患者血浆中的治疗药物。
Microchem J. 2022 Aug;179:107580. doi: 10.1016/j.microc.2022.107580. Epub 2022 May 13.
3
Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design.
冠状病毒复制-转录复合物的结构和功能及其与 SARS-CoV-2 药物设计的相关性。
Nat Rev Mol Cell Biol. 2022 Jan;23(1):21-39. doi: 10.1038/s41580-021-00432-z. Epub 2021 Nov 25.
4
Accelerated stability study of the ester prodrug remdesivir: Recently FDA-approved Covid-19 antiviral using reversed-phase-HPLC with fluorimetric and diode array detection.酯前药瑞德西韦的稳定性加速研究:最近 FDA 批准的用于治疗 COVID-19 的抗病毒药物,采用反相高效液相色谱法,荧光和二极管阵列检测。
Biomed Chromatogr. 2021 Dec;35(12):e5212. doi: 10.1002/bmc.5212. Epub 2021 Aug 9.
5
Green and sensitive spectrofluorimetric determination of Remdesivir, an FDA approved SARS-CoV-2 candidate antiviral; application in pharmaceutical dosage forms and spiked human plasma.绿色敏感的荧光光度法测定瑞德西韦,一种获得 FDA 批准的 SARS-CoV-2 候选抗病毒药物;在药物制剂和加标人血浆中的应用。
Anal Methods. 2021 Jun 21;13(23):2596-2602. doi: 10.1039/d1ay00469g. Epub 2021 May 21.
6
A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019.索磷布韦和达卡他韦治疗2019冠状病毒病的综述
New Microbes New Infect. 2021 Jul;42:100895. doi: 10.1016/j.nmni.2021.100895. Epub 2021 May 7.
7
A nidovirus perspective on SARS-CoV-2.一种尼多病毒视角下的 SARS-CoV-2。
Biochem Biophys Res Commun. 2021 Jan 29;538:24-34. doi: 10.1016/j.bbrc.2020.11.015. Epub 2020 Nov 13.
8
Chinese guidelines related to novel coronavirus pneumonia.新型冠状病毒肺炎相关中国指南。
J Mark Access Health Policy. 2020 Oct 8;8(1):1818446. doi: 10.1080/20016689.2020.1818446.
9
Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study.奥司他韦是否适合对抗 COVID-19:计算机评估、体外和回顾性研究。
Bioorg Chem. 2020 Nov;104:104257. doi: 10.1016/j.bioorg.2020.104257. Epub 2020 Sep 2.
10
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects.瑞德西韦治疗 COVID-19 的安全性、耐受性和药代动力学:一项在健康受试者中的研究。
Clin Transl Sci. 2020 Sep;13(5):896-906. doi: 10.1111/cts.12840. Epub 2020 Aug 5.